News
Medable, Tufts CSDD value AI gain at $21m net per programme
New analysis from Tufts CSDD and Medable shows AI agent value to oncological drug development programmes at up to $21m each.
Digital
Sponsored
Technology solutions for smarter clinical trials: Inventus
In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
Digital
Changing Faces: Digital and supplier hires, June and July 20...
The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.
News
OpenAI Foundation pledges $100m to boost hepatitis C cure ra...
The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
News
Google adds insulin resistance tracker to wearables
In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.
Debates
News
Press Releases
Editor's Picks
Editor's Picks
